Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 2
2006 1
2007 3
2008 4
2009 2
2010 4
2011 3
2012 1
2013 4
2015 4
2016 2
2017 4
2018 2
2019 6
2020 9
2021 10
2022 13
2023 13
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis.
Caruso I, Di Gioia L, Di Molfetta S, Cignarelli A, Palmer SC, Natale P, Strippoli GFM, Perrini S, Natalicchio A, Laviola L, Giorgino F. Caruso I, et al. Among authors: natalicchio a. EClinicalMedicine. 2023 Sep 12;64:102181. doi: 10.1016/j.eclinm.2023.102181. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37719418 Free PMC article.
Impaired Leptin Signalling in Obesity: Is Leptin a New Thermolipokine?
Genchi VA, D'Oria R, Palma G, Caccioppoli C, Cignarelli A, Natalicchio A, Laviola L, Giorgino F, Perrini S. Genchi VA, et al. Among authors: natalicchio a. Int J Mol Sci. 2021 Jun 16;22(12):6445. doi: 10.3390/ijms22126445. Int J Mol Sci. 2021. PMID: 34208585 Free PMC article. Review.
Diabetes and cancer: Pathophysiological fundamentals of a 'dangerous affair'.
Cignarelli A, Genchi VA, Caruso I, Natalicchio A, Perrini S, Laviola L, Giorgino F. Cignarelli A, et al. Among authors: natalicchio a. Diabetes Res Clin Pract. 2018 Sep;143:378-388. doi: 10.1016/j.diabres.2018.04.002. Epub 2018 Apr 19. Diabetes Res Clin Pract. 2018. PMID: 29679627 Review.
Pharmacological modulation of adaptive thermogenesis: new clues for obesity management?
Genchi VA, Palma G, Sorice GP, D'Oria R, Caccioppoli C, Marrano N, Biondi G, Caruso I, Cignarelli A, Natalicchio A, Laviola L, Giorgino F, Perrini S. Genchi VA, et al. Among authors: natalicchio a. J Endocrinol Invest. 2023 Nov;46(11):2213-2236. doi: 10.1007/s40618-023-02125-0. Epub 2023 Jun 28. J Endocrinol Invest. 2023. PMID: 37378828 Free PMC article. Review.
Evaluation of a digital tool supporting therapeutic decision making for the personalized management of patients with type 2 diabetes not treated with insulin: A pilot study.
Di Molfetta S, Laviola L, Natalicchio A, Leonardini A, Cignarelli A, Bonizzoni E, Acmet E, Giorgino F. Di Molfetta S, et al. Among authors: natalicchio a. Diabetes Res Clin Pract. 2023 Sep;203:110836. doi: 10.1016/j.diabres.2023.110836. Epub 2023 Jul 20. Diabetes Res Clin Pract. 2023. PMID: 37478979 Free article. Clinical Trial.
Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis.
Cignarelli A, Genchi VA, Le Grazie G, Caruso I, Marrano N, Biondi G, D'Oria R, Sorice GP, Natalicchio A, Perrini S, Laviola L, Giorgino F. Cignarelli A, et al. Among authors: natalicchio a. Front Endocrinol (Lausanne). 2022 Feb 21;13:846903. doi: 10.3389/fendo.2022.846903. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35265043 Free PMC article. Review.
77 results